Managing Covid-19 Pandemic Procedure - Rev01 (Project Site)
Managing Covid-19 Pandemic Procedure - Rev01 (Project Site)
PROCEDURE TITLE
Contents
PURPOSE
SCOPE
DEFINITION
RESPONSIBILITY
PROCEDURE
CROSS REFERENCE
FLOW CHART
APPENDICES
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 2 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 2 of 64
02
NAME ABD MUTALIB ABD GAPAR NAME MR. KHEW CHECK KIET
POSITION HEAD - HSE POSITION MANAGING DIRECTOR
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 3 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 3 of 64
Amendment History
1 PURPOSE
2 SCOPE
3 DEFINITION
4 RESPONSIBILITIES
Company
Secretary.
- Propose mitigation measure for
COVID-19 Special Task implementation
- Internal & external communication
Force (HQ)teering
- Coordinate Implementation for consistency
Committee (SC) - Monitor & collate track cases
- Update latest legal & other requirements
Note: Existing Task Forcecommittees may be dissolved when the pandemic is over
Scretariate
R.THANARAJ
Gadang LandE HR
GL HR
GL QU
COVID-19
All of the Business Units/Project shall establish specific task force with clear
roles and responsibilities identified as per sample below:
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 11 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 11 of 64
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 12 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 12 of 64
5 PROCEDURE
APPENDIX A
COVID-19 Case Definition
APPENDIX B
Roles & Responsibilities
APPENDIX C
COVID-19 Preventive Measure
Management of COVID-19
Pandemic
APPENDIX D
Management of CLQ & /WQ/CQQ
APPENDIX E
COVID-19 Testing & Contact Tracing
APPENDIX F
Management of COVID-19 Cases
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 15 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 15 of 64
A detailed guideline in establishing and managing CQQ, WQ, CLQ and QQ are
described Appendix D.
Each project site workplace (e.g.: MG/project site, sales gallery and etc.)
shall be registered in MySejahtera apps for contact tracing
purposes by MOH.
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 17 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 17 of 64
Details of process of COVID-19 testing and contact tracing are being described
Appendix E.
Management of cases varies depending upon type and source of test. Please
refer Appendix F for specific process to handle each type of cases. There are
several different type of COVID-19 case identification and Gamuda had
established a specific process in handling each of the cases identified. Refer to
Appendix F for details.
6 CROSS REFERENCE
7 FLOW CHART
N/A
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 19 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 19 of 64
8 APPENDICES
b) Epidemiological criteria
Attended an event OR areas associated with
known COVID-19 cluster OR red zones1;
Note 1: The list of red zone areas is based on the 14 days
moving data by mukim/zone/precinct updated daily in
the CPRC telegram: https://t.me/cprckkm
OR
Indirect Contact - Persons who have had contact with Indirect Contact
(Level 2) (Level 2)
b) QSHSE Department
GB-MSP-GPC-0001
Revision: 2
MANAGING OF COVID-19 PANDEMIC Date: 08 19 Jan
2021
Page: 26 of 64
Ref.No:
GAMUDA BUILDING UNIT GE/GBU/GEN/QSHE/
MSP/001
Rev : 2
MANAGEMENT SYSTEM PROCEDURE Date: 22 January 2021
Page: 26 of 64
c) COVID-19 Coordinator
A position required by DOSH
Monitor implementation of preventive measures
Advise management on necessary preventive measures in line with the
requirements/recommendations of Ministry of Health, World Health
Organization (WHO) and International Labour Organization (ILO).
Investigate and notify management and ERT on any person with
symptoms at workplace.
Ensure equipment and facilities used as preventive measure & for
emergency respond such as thermometer, hand sanitizers are available,
usable and adequate.
Ensure attendance and health screening records at workplace are kept.
Record and analyse COVID-19 risk control measures and submit report
to DOSH.
i) All staffs/workers/visitors
Comply with the legal requirements and as stated in this procedure and
related work instructions.
Immediately notify superior when COVID-19 related symptom/s develop
If staff/worker categorized as Confirmed Case/Probable Case/Close
Contact/Casual Contact, the staff/worker shall provide information
as requested by Contact Tracing team.
All staff/workers shall download and install “MySejahtera”
application (available in Galeri Aplikasi Mudah Alih Kerajaan
Malaysia (GAMMA), Apple App Store, Google Play Store dan
Huawei AppGallery) for MOH contact tracing.
GB-MSP-GPC-0001
Revision: 2
Date:
MANAGING OF C
GAMUDA BERHAD
MANAGING OF C
26 Nov 2020
Page: 29 of 64
Ref.No:
GE/GBU/GEN/QSHE/MSP/001
Rev : 2
Date: 22 January 2021
MANAGING OF COVID-19 PANDEMIC Page: 29 of 64GB-MSP-GPC-
0001
Revision: 2
Date: 19 Jan 2021
Page: 29 of 64
Enforcement
Staff responsible to ensure safe and
healthy work environment at home
WFH Safety
& Health
Guideline
Management of CLQ / WQ
1.
2.
2.1. Clustering of CLQ/WQ
2.2.
2.3.
2.4.
2.5.
2.6.
2.7.
2.8. Requirements for CLQ/WQ
Reporting Process
- Workers that are suspected to be infected with COVID-19
shall be reported to the respective CLQ/WQ Wardens.
- CLQ/WQ Wardens then shall be responsible to report
the case to the CLQ/WQ Management immediately.
-
- CLQ/WQ Management are responsible to report and
ensure the workers who are suspected to be infected will
be are tested for and necessary action to be taken.
Quarantine Process
- Quarantine process are being described in 2. (ii)
Management of Centralized Quarantine Quarters (CQQ).
Disinfection Process
- Every cluster of CLQ/WQ that have workers that are
identified as Confirmed Case of COVID-19 shall be
disinfected by the CLQ/WQ Management. Refer to Annex
8: Infection Prevention And Control (IPC) Measures In
Managing Person Under Surveillance (Pus), Suspected,
Probable Or Confirmed Coronavirus Disease (Covid-19)
for details.
- CLQ/WQ Management shall keep the disinfection records in
case of inspection by the Authority.
3.1.6.
3.1.7. Discharge from CQQ
The biohazard yellow plastic bags and bin are not allowed to
use for other purposes.
All sharp objects such as syringes and needles shall be
placed in a biohazard puncture resistant and leak tight bin.
Dedicated wheel bin, trolley or cart shall be used to transport
the clinical waste and dedicated internal route for
transportation of clinical waste shall be identified by CQQ
management.
A washing down and disinfectant area for clinical waste bin,
trolley or cart cleaning/ disinfectant purposes shall be
identified and located adjacent to the clinical waste storage.
All waste from cleaning processes shall be discharged to the
sewer pipe line.
Labelling of plastic bag and bin shall contain biohazard
symbol (Infectious Substances), waste code and name, first
waste generated date, waste generator name, address and
telephone number as per Regulation 10, Environmental
Quality (Scheduled Wastes) Regulations 2005.
The CQQ management shall register eSWIS with DOE for the
following;
- Notification to DOE (within 30 days from the date of clinical
waste generated)
- Inventory (to be updated once a month)
- Consignment Note (raise when disposing clinical waste)
A Contractor/ vendor licensed with DOE shall be appointed by
CQQ management to handle the collection of such waste at
an agreed interval. A waste card shall be provided to
Contractor/ vendor during clinical waste disposal.
Contractor/ vendor who collects and disposes clinical waste
shall be equipped with poly-coated isolation gown (universal
blue colour), non-woven boot cover, disposable rubber
gloves, disposable full-face shield and fluid shield.
A clinical waste management/ handling training shall be
conducted by CQQ management to the related staff/ workers.
The CQQ management shall ensure the handling of clinical
waste comply with the following requirements at all time;
- Environmental Quality (Scheduled Wastes) Regulations
2005.
- Guidelines on The Handling and Management of Clinical
Wastes in Malaysia 2009.
-
v. Laundry Facilities
If the laundry facilities are to be provided in CQQ, such
facilities shall be able to provide hot water (90⁰C) washing. All
the laundry from the quarantine workers shall be washed 1st
time using hot water, and then with freshly prepared 1%
sodium hypochlorite and cold water.
If the laundry is to be done by external, the same requirement
shall be clearly communicated to the vendor.
Workers responsible to collect such linen from quarantine
room shall equip with polycoated isolation gown (universal
blue colour), non-woven boot cover, disposable rubber
gloves, disposable full-face shield and fluid shield.
a) Each BU/Project are responsible to arrange the necessary testing arrangement as part
of preventive measure of COVID-19.
b)
c) Each BU/Project shall prepare a Testing Plan for the next 6 months and the plan
shall cover the Baseline Testing (RT-PCR/T-PCRRTK-Ag). and scheduled monitoring
testing either RT-PCR, RTK-An or RTK-Ab. biweekly Continuous Testing Internal RT-
PCR.
d)
Stages Timetable
Baseline Testing (RT-PCR) 1 April – 14 May
All staff and workers to be tested and cleared prior to being
allowed on UG sites / offices
Scheduled Monitoring Testing (Internal RT-PCR) 15 May – 30 Sep
All staff and workers to be tested on a bi-weekly basis and
effectiveness of testing regime to reviewed over initial 2-
month period.
Scheduled Monitoring Testing (RTK Antibody) 15 May – 30 Sep
All staff and workers to be tested on a weekly basis and
effectiveness of testing regime to reviewed over initial 2-
month period.
Total 6 months
Sample of a Screening Test Plan
e) In principle, all employees and workers will shall be tested with RT-
PCR/RTK-Ag to establish a baseline.
f) Testing frequency and requirements will be reviewed based on the
situational development of COVID-19 cases and in light of effectiveness of
preventive and mitigation measures, and developments in testing tools
availability and resources.
g) Each BU/Project are responsible to arrange the necessary testing arrangement
as part of preventive measure of COVID-19.
h) The testing arrangement can be divided into several types:
i) Baseline RT-PCR
j) Scheduled Monitoring Testing – Internal RT-PCR or RTK Ab
k) All of the testing conducted shall be recorded.
l) Upon learning of a positive result of Confirmed Case/Close Contact/Probable
Case, A-Card Holder for Testing shall notify PIC for his/her further action.
m)
a) The following items must be considered when deciding the testing frequency and
groups of people to be tested:
The segregation / clustering of workers in different CLQ / Quarters.
Availability of proper preventive mitigation measures at CLQ and work
place.
Practice and enforcement of physical distancing and hygiene practices.
Work from Home arrangement of staff.
Effective induction, education and communication of SOPs.
Strict enforcement of the above.
b) The frequency of re-testing should be carefully reviewed based on the situational
development.
Testing Arrangement
Baseline RT-PCR
a) In principle, all employees and workers shall be tested with RT-PCR by
testing agencies to establish a baseline.
a) Upon identification of a positive case, A-Card Holder for testing shall notify PIC
shall be notified for his/her immediate action.
b) PIC shall conduct Contact Tracing to MOH
c) Internal RT-PCR case: PIC then are responsible to update the Master List
Positive Patients via this link:
d) https://drive.google.com/file/d/1wp49ci_vpCSksN_E9ZxM6NhCZ9Kn9NPk/view?
usp=sharing. Figure below show the sample of the register.
Note: All forms shall be filled up online ONLY and all of the information shall be kept
private and confidential. The Master List Positive Patients shall record information on
cases that are reported externally as well as from internal RT-PCR test conducted
biweekly.
f) Upon completion of every internal RT-PCR test cycle, each of the PIC shall
submit a PCR Test Cycle Report – Highlights as shown in Figure 5 to the
Management (Group Managing Director and Chairman of COVID-19 Steering
Committee).
g) External identified cases (Confirmed Case): PIC are responsible to update the
COVID-19 Swab Test Summary as shown in Figure 6 below.C
h) Contact tracing shall then be conducted immediately by PIC to identify the Close
Contact.
i) PIC shall record down the information on Close Contact that identified from
external case in the Close Contact PCR Schedule as shown in Figure 7.
Figure 5 Sample of PCR Test Cycle Report - Highlights
ontact tracing shall then be conducted immediately by PIC to identify the
Close Contact.
GB-CWI-GPC-0002
Revision: 2
Date: 26 Nov 2020
Page: 52 of 64
Ref.No:
GE/GBU/GEN/QSHE/MSP/001
Rev : 2
Date: 22 January 2021
MANAGING OF COVID-19 PANDEMIC Page: 52 of 64GB-MSP-
GPC-0001
Revision: 2
Date: 19 Jan 2021
Page: 52 of 64
Figure 6 Sample of COVID-19 Swab Test Summary
a) Upon identification of a positive case, A-Card Holder for testing shall notify
COVID Coordinator within 15 minutes and provide necessary info:
Name of staff/worker.
Nationality.
Work location.
Employer – Gamuda/Main-con/Sub-con.
Place of residence – CLQ/outside.
Test date.
Type of testing (RT-PCR, RTK-An or RTK Ab)
b) Contact tracing shall then be conducted immediately by COVID Coordinator
following the process described in Appendix G.
c) Within 3 hours upon receiving information from A-Card Holder, COVID
Coordinator shall send preliminary report using the COVID-19 Trace Report to
Group MD, Managing Director for GE, CEO for GL, Project Director/HOD
(where applicable) and Steering Committee containing the following
information:
Personal details of the Patients
Was the positive case symptomatic or asymptomatic?
Name of CLOSE and CASUAL contacts.
Isolation and quarantine arrangements for CLOSE and CASUAL
contacts.
Impact of quarantine to work.
Steps to mitigate impact.
d) Within 24 hours upon receiving information from A-Card Holder, COVID
Coordinator shall send detailed final report using the same COVID-19 Trace
Report to Group MD, Managing Director for GE, CEO for GL, Project
Director/HOD (where applicable) and Steering Committee containing but
not limited to the following information:
Information that was sent as stated in item (c) above.
Chronology of events / Schematic of the case.
Observations and lessons learnt.
e) The following is the number referencing guideline for the COVID-19 Trace
Report:
Case / Test Type / Business Unit / Project
Number Name
Example:
i. 62 / IgM/IgG / SSP / UGW
ii. 58 / PCR / Bestari / DJ-2T Office
iii. 64 / IgM / SSP / AG
f) The originator of the COVID-19 Trace Report shall request the Case Number
from GB HR.
Below is the flow chart explaining on the process of Escalation of Information
for Confirmed Case and Probable Case.
Sample of COVID-19 Trace Report
COVID 19 Trace Report (Preliminary Report)
Mob:
Covid Coordinator
Email:
1.4 Employer
3.0 Contact Tracing Information (Preliminary Report target to identify Close Contacts & Casual Contacts)
Key:
Contact
information Work on
Job
Contacts IC/PP e.g. Employe Room Work Other SSP/Gamuda Contac Additional
Rol Action
Name Number Address, r Share Colleague Associate site and t Type Information
e
phone, if where
known
Ref.No:
GE/GBU/GEN/QSHE/MSP/001
Rev : 2
Date: 22 January 2021
Page: 59 of 64GB-MSP-
MANAGING OF COVID-19 PANDEMIC GPC-0001
Revision: 2
Date: 19 Jan 202126 Nov
2020
Page: 59 of 64
Confirmed Case /
Suspected Case / PUS
Employee to inform
superiorHOD/HOP MOH take over
SuperiorHOD/HOP to immediately
isolate the patient and report to PIC & Discharged from
COVID Coordinator hospital / completion of
quarantined period
COVID
CoordinatorCOVID PIC COVID Coordinator RT-PCR / RTK-
Coordinator AgReturn to Work
Disinfection of workplace
(if necessary) in line with
patient’s movement
External
Internal Communication
Communication
(if applicable)
(if applicable)
Flow Chart No. 2 - Probable Case (RTK Ab)
The below process applicable for 1st RTK test conducted on a person who have not tested
positive before (RT-PCR)
RTK-Antibody Test
Negative
Test No further actions
Result required.
Positive
Quarantine Patient & perform RT- Quarantine Patient & perform RT-
PCR test PCR test
1. Contact tracing for Close & Casual 1. Contact tracing for Close & Casual Contacts**
Contacts 2. Close Contact to be quarantined & perform RT-PCR
2. Quarantine for Contacts not required test
unless symptoms are displayed
3. RT-PCR test not required for Contacts
Notify in S/Com Whatsapp group & Submit
unless Patient tested positive for RT-
Preliminary Report to Management***
PCR
4. Not required to notify S/Com and submit
Preliminary Report to Management
RT-PCR Test
Work examples for IgM only cases (positive & negative relate to IgM only)
Example 1 Example 2 Example 3
Test Day
Test Result Actions Test Result Actions Test Result Actions
Day 1 (initial test) Positive Quarantine Positive Quarantine Positive Quarantine
Day 2 Positive Quarantine Positive Quarantine Negative Release Patient
Day 3 Positive Quarantine IgM/IgG +ve Do PCR test
Release Patient if
RT-PCR is -ve.
Day 4 Positive Quarantine
Day 5 Positive Do PCR test.
Release Patient
if RT-PCR is -ve.
Flow Chart No. 21 – Management of Close ContactCases Confirmed by
MOH / External Lab
*Notes:
Factor to decide home/CQQ
quarantined:
Persons who have had contact Test Result
with the Confirmed Case less than
15 minutes duration at a distance
of more than 1 meter.
Persons who had spent less than
15 minutes duration in an enclosed
area with the Confirmed Case, e.g.
Positive Negative Inconclusive
meeting room, utility room.
Isolate
Patient &
Start
Contact Isolate Contact
Tracing Patient Tracing
(need not
isolate for
Close
Contact)
Quarantine Quarantine
at CLQ Isolate & No further NEGATIVE
at Home Result
Test action (Resume
based on work)
symptom
(*HOD to
decide)
Retest on
Retest Day-5 and GLab to POSITIVE
every 5- Day-9 (Drive Notify
Days through MOH
(unless Internal RT-
instructed PCR Test) Note:
otherwise (Unless Glab to coordinate with
by MOH) instructed MOH take Patient for 2nd Testing
otherwise by over
MOH)
Discharged from
hospital / recovered
Notes:
i. 3rd Party labs shall notify MOH on all Confirmed Cases. PIC shall ensure sufficient information are provided to the lab for
this notification.
ii. PIC shall promptly notify GLab on all test results from 3rd Party labs for compilation and analysis (Refer attached Google
Form)
iii. Close ContactFlow Chart
shall be No.4
quarantine for–a Management
period of 10 days. of Close and Casual Contact
iv. For failing to comply with the instructions / SOPs, staff/worker can be subjected to disciplinary action. Such action will
depend on the severity and impact of the non-compliance
Case Identified
Casual
Close Contact
Contact
Notes:
Factor to decide home/CQQ
quarantined:
Persons who have had
Quarantine Quarantine
Isolate & contact with the Confirmed
at CLQ at Home
Test Case less than 15 minutes
based on duration at a distance of more
symptom than 1 meter.
(*HOD to Persons who had spent less
decide) than 15 minutes duration in
Retest on an enclosed area with the
Retest Day-5 and Confirmed Case, e.g. meeting
every 5- Day-9 (Drive room, utility room.
Days through
(unless Internal RT-
instructed PCR Test)
otherwise (Unless
by MOH) instructed
otherwise by
Test Result MOH)
–
Refer Flow
Chart No.3
Confirmed Case /
Suspected Case / PUS
Adhere to MOH
Self assess for
instructions & update
symptomsRT-PCR /
PICPIC
RTK-Ag
Contact Tracing
Refer to Flow